- PROFESSOR Psychiatry
Psychiatry, American Board of Psychiatry and Neurology
MD, Cornell University Medical College
University of Southern California Med Center
Cedars-Sinai Medical Center
National Institutes of Health - Clinical Center
Interests: Electroconvulsive Therapy (ECT), Treatment-resistant Depression, Mood Disorders, Neuropsychiatry, Brain Stimulation techniques
Charles H. Kellner, MD is Professor of Psychiatry and Director of the Division of Geriatric Psychiatry at the Mount Sinai School of Medicine and Director of the ECT service at the Mount Sinai Hospital.
Dr. Kellner received his M.D. from Cornell University Medical College. He did his internship at Los Angeles County Medical Center and his Psychiatry residency at Cedars-Sinai Medical Center. He did a fellowship in Biological Psychiatry at the National Institute of Mental Health in Bethesda, Maryland. He was on the faculty of the Medical University of South Carolina in Charleston from 1984-2002, where he directed the ECT service. He was Chair of the Department of Psychiatry at New Jersey Medical School from 2002-2008 and director of the ECT service at University Hospital in Newark.
He has dedicated his career to the study of ECT and is Editor Emeritus of the Journal of ECT. He has led the collaborative ECT research group CORE (Consortium for research in ECT) for the past decade in the performance of NIMH-sponsored multi-site research protocols.
He has over 150 publications, most related to ECT and mood disorders. He has authored the APA published text, Handbook of ECT. He is a member of the APA Task Force on ECT, currently revising the APA recommendations on ECT.
Popeo D, Kellner CH. ECT for Parkinson's disease. Med Hypotheses 2009 Oct; 73(4): 468-469.
Kellner CH, Fink M. Electroconvulsive therapy in the treatment of intractable status epilepticus. Epilepsy Behav 2009 Sep; 16(1): 189-190.
Rasmussen KG, Mueller M, Rummans TA, Husain MM, Petrides G, Knapp RG, Fink M, Sampson SM, Bailine SH, Kellner CH. Electroconvulsive therapy: a selected review. J Clin Psychiatry 2009 Feb; 70(2): 232-237.
Ligas A, Petrides G, Istafanous R, Kellner CH. Successful electroconvulsive therapy in a patient with intellectual disability and bipolar disorder, with catatonic features misdiagnosed as encephalopathy. J ECT 2009 Sep; 25(3): 202-204.
Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K, Mueller M, Bernstein HJ, O'Connor K, Smith G, Biggs M, Bailine SH, Malur C, Yim E, McClintock S, Sampson S, Fink M. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 2006 Dec; 63(12): 1337-1344.
Kellner CH, Fink M, Knapp R, Petrides G, Husain M, Rummans T, Mueller M, Bernstein H, Rasmussen K, O'Connor K, Smith G, Rush AJ, Biggs M, McClintock S, Bailine S, Malur C. Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. Am J Psychiatry 2005 May; 162(5): 977-982.
Greenberg RM, Kellner CH. Electroconvulsive therapy: a selected review. Am J Geriatr Psychiatry 2005 Apr; 13(4): 268-281.
Husain MM, Rush AJ, Fink M, Knapp R, Petrides G, Rummans T, Biggs MM, O'Connor K, Rasmussen K, Litle M, Zhao W, Bernstein HJ, Smith G, Mueller M, McClintock SM, Bailine SH, Kellner CH. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. J Clin Psychiatry 2004 Apr; 65(4): 485-491.
Petrides G, Fink M, Husain MM, Knapp RG, Rush AJ, Mueller M, Rummans TA, O'Connor KM, Rasmussen KG Jr, Bernstein HJ, Biggs M, Bailine SH, Kellner CH. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 2001 Dec; 14(4): 244-253.
Kellner CH, Rubinow DR, Gold PW, Post RM. Relationship of cortisol hypersecretion to brain CT scan alterations in depressed patients. Psychiatry Res 1983 Mar; 8(3): 191-197.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Kellner did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.
Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.
Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.
1425 Madison Avenue
Icahn medical Institute 4th Floor Room L4-33
New York, NY 10029
1425 Madison Avenue
4th Floor Room 4-33
New York, NY 10029
- Monday 9:00am - 5:00pm
- Tuesday 9:00am - 5:00pm
- Wednesday 9:00am - 5:00pm
- Thursday 9:00am - 5:00pm
- Friday 9:00am - 5:00pm
- Personal Check